BioKey (Cayman) Inc. Distribution of Shares Postponed by ABVC

What Happened
ABVC BioPharma, Inc. (ABVC), the former parent of BioKey (Cayman), Inc., has postponed the previously announced distribution of BioKey ordinary shares that was scheduled for August 3, 2026. ABVC said the delay will allow more time to complete administrative, regulatory and tax-related matters. ABVC is coordinating with The Nasdaq Stock Market LLC, The Depository Trust Company (DTC) and its transfer agent on revised distribution mechanics and new dates. ABVC will announce the revised distribution date and a new ex-dividend date once finalized.

Key Details

• Postponement announced by ABVC on August 3, 2026 (reported in BioKey's Form 8-K filed Aug 5, 2026, Item 8.01).
• Distribution ratio unchanged: 0.169464 BioKey ordinary shares per one share of ABVC common stock.
• Previously announced record date remains unchanged (ABVC has not changed the record date).
• Previously announced ex-dividend date will be revised; ABVC will announce the new ex-dividend and distribution dates after completion of remaining matters.

Why It Matters
For ABVC shareholders expecting to receive BioKey shares on August 3, the timing is now uncertain — shares will not be distributed as scheduled and the ex-dividend date will change. The distribution ratio and record date staying the same preserves the planned allocation, but investors should monitor ABVC announcements for the new distribution and ex-dividend dates because those dates determine eligibility and when trading/ownership of BioKey shares will begin. This filing is procedural and does not report financial results or changes in price allocation.